Salvinorin C
| Clinical data | |
|---|---|
| Drug class | κ-Opioid receptor ligand |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C25H30O9 |
| Molar mass | 474.506 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Salvinorin C is a naturally occurring terpene of the salvinorin family and minor constituent of Salvia divinorum. It showed 256-fold lower affinity for the κ-opioid receptor (KOR) than the related compound salvinorin A (Ki = 1,022 nM vs. 4 nM, respectively). The drug's functional activity at the KOR was not assessed or reported. Daniel Siebert reported via self-experimentation that salvinorin C has no psychoactive or hallucinogenic effects in humans. Salvinorin C was first described in the scientific literature by Leander J. Valdés III and colleagues in 2001. Its weak activity at the κ-opioid receptor was reported by Bryan L. Roth and colleagues in 2005, while its properties in humans were reported by Siebert in 2004.
Category:
- Drugs not assigned an ATC code